Gabapentin and Pregabalin in Residential Treatment: The One-Week Taper Minimum, the Opioid Breathing Risk, and What to Tell Admissions

Gabapentin (brand name Neurontin) and pregabalin (Lyrica) are prescribed every day for nerve pain, seizures, and sometimes off-label for anxiety, sleep, or alcohol withdrawal. Because they arrive from a pharmacy with a doctor’s name on the label, many people don’t think of them as part of their substance use at all. In residential admissions, that is exactly why they get missed. This guide covers how these medications are handled when someone enters residential treatment, why stopping them suddenly is not safe, and what to have ready before you call admissions.

The Short Answer: Gabapentin Should Not Be Stopped Abruptly

Gabapentin should never be stopped “cold turkey” on admission to residential treatment. The FDA-approved prescribing information for Neurontin directs that when the medication is reduced or discontinued, it be done gradually over a minimum of one week, and it warns that antiepileptic drugs should not be stopped abruptly because of the possibility of increased seizure frequency. People who have been taking more than prescribed, or combining gabapentin with alcohol, benzodiazepines, or opioids, generally need a slower, medically supervised taper than that one-week floor, planned by a prescriber who knows their full history.

Why Gabapentin and Pregabalin Misuse Is Often Missed

From the admissions side, the pattern is consistent: a person describes their alcohol or opioid use in detail, then mentions gabapentin almost as an afterthought, or not at all. Several things drive that:

• It is prescribed, not purchased: A pharmacy label makes the medication feel like healthcare rather than substance use, even when the daily amount has drifted well past the prescription.
• Gabapentin is not federally controlled: Pregabalin is a Schedule V controlled substance under federal law, but gabapentin is not federally scheduled, so it can fall outside the questions people expect to be asked.
• It is used to manage other substances: Some people use gabapentin to soften opioid withdrawal or to blunt alcohol cravings, so they see it as part of the solution rather than part of the problem.
• It amplifies other depressants: Taken with opioids or alcohol, gabapentin can intensify sedation, which is part of why some people take extra and part of why the combination is dangerous.

None of this means a gabapentin prescription is a problem in itself. Many people take it exactly as directed and benefit. The clinical question in admissions is simply whether the amount, the source, and the combination with other substances match the prescription.

The Breathing Risk When Gabapentinoids Are Combined With Opioids

In December 2019, the U.S. Food and Drug Administration added warnings that gabapentin and pregabalin can cause serious breathing difficulties in people with respiratory risk factors, including people who also use opioids or other central nervous system depressants, older adults, and people with lung conditions such as COPD. This matters for residential admissions because many people entering treatment for opioid use disorder are also taking gabapentin, prescribed or not.

The Centers for Disease Control and Prevention (CDC) describes how combining opioids with other sedating substances raises overdose risk. A complete medication list lets the medical team plan withdrawal care and make sure naloxone is part of the safety plan. If you are worried about someone right now, and they are hard to wake, breathing slowly, or making snoring or gurgling sounds, call 911.

What Withdrawal Can Look Like in the First Week

People who have been taking high daily amounts and stop suddenly may report anxiety, agitation, restlessness, insomnia, sweating, nausea, and a rebound of the pain the medication was treating. Seizures are the most serious risk, especially for anyone with a seizure history or who is also coming off alcohol or benzodiazepines.

That last point is critical. Alcohol withdrawal and benzodiazepine withdrawal both carry a risk of seizures and can be life-threatening. Medical supervision is required. When gabapentin or pregabalin dependence overlaps with either of those, withdrawal planning needs to account for all of them at once. Families sometimes notice the first week as a person who seems “on edge” and unable to sleep, and that is a reason to keep the medical team informed, not a reason to give an extra dose from the home supply.

The National Institute on Drug Abuse (NIDA) notes that medically managed withdrawal is only the first stage of treatment and is rarely enough on its own to sustain recovery. The taper is the start, not the treatment.

What to Tell Admissions: A Checklist to Fill In Today

Before you call, take five minutes and write down the following. If you are calling for a family member, gather what you can and leave the rest blank. Admissions can work with partial information, but not with information nobody mentions.

1. Exact product and strength: Gabapentin or pregabalin, the milligram strength printed on the bottle, and whether it is capsules, tablets, or liquid.
2. Prescribed amount versus actual amount: What the label says per day, and what is actually being taken per day. Count what is left in the bottle against the fill date if you are unsure.
3. Source: One prescriber, more than one prescriber, or obtained from someone else. This is clinical information, not a judgment.
4. Time of the last dose: Withdrawal planning depends on it.
5. Everything else taken alongside it: Opioids, buprenorphine or methadone, benzodiazepines, alcohol, sleep medications, or muscle relaxants.
6. Seizure history: Any past seizure, including during a previous withdrawal.
7. Why it was first prescribed: Nerve pain, seizures, anxiety, or sleep. The underlying condition still needs a treatment plan after the taper.

Bring the original pharmacy bottles on admission day. Our admissions team can walk you through what to bring and how prescriptions are reconciled when you call (877) 328-1968.

How Residential Treatment Handles the Taper

In a residential setting, gabapentin or pregabalin is typically reviewed by the medical team during intake. The prescriber confirms the actual daily amount, considers other substances and health conditions, and sets a taper schedule. Doses are held and dispensed by staff rather than self-administered, which removes the guesswork and the temptation to take extra on a hard night.

Because the taper usually runs alongside therapy rather than before it, people can begin residential treatment work in the first days instead of waiting for withdrawal to finish. If pain was the original reason for the prescription, the plan should include non-addictive pain strategies and a handoff to an outpatient prescriber at discharge. The Substance Abuse and Mental Health Services Administration (SAMHSA) emphasizes treating co-occurring physical and mental health conditions alongside substance use, and chronic pain is one of the most common examples.

A residential stay is not the right level of care for everyone who takes gabapentin. Someone taking it exactly as prescribed, with no other substance use, may simply need their own prescriber to manage a taper. Residential care makes sense when the medication is part of a broader pattern, when other depressants are involved, or when previous attempts to cut back on their own have not held.

Questions to Ask Before You Commit to a Program

• Does the program have a prescriber on staff who reviews gabapentin and pregabalin at intake, rather than stopping all non-essential medications?
• How is a taper handled when alcohol, benzodiazepines, or opioids are also involved?
• Is naloxone included in the discharge plan for anyone with opioid use?
• What happens to the original pain or anxiety condition after the taper ends?
• Will my insurance cover the stay? You can start that process through our insurance verification page.

A Note From the Clinical Side

The most useful thing a person or family can do is mention gabapentin or pregabalin on the very first call, even if it seems minor. Medication that is disclosed can be tapered safely. Medication that surfaces on day three, after a withdrawal symptom nobody planned for, is harder for everyone. If you are not sure whether it matters, assume it does and say it out loud.

This article was written by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i. To talk through a specific situation confidentially, call (877) 328-1968.

This article is for educational purposes only and is not medical advice. Do not stop, reduce, or change any prescribed medication without guidance from your prescriber. Alcohol and benzodiazepine withdrawal can cause seizures and require medical supervision. If you or someone you know is in immediate danger, call 911. For a mental health or suicidal crisis, call or text 988.